Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Howard

Showing results (131-140 of 153) with videos related to

Pageof 16
Sort By:
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|April 24, 2025
Free-breathing, non-contrast, three-dimensional whole-heart coronary magnetic resonance imaging for the identification of culprit and vulnerable atherosclerotic plaqueReza Hajhosseiny, Adam Hartley, Graham Cole, et al.
Journal of Cardiovascular Electrophysiology|September 20, 2018
Outcomes of paroxysmal atrial fibrillation ablation studies are affected more by study design and patient mix than ablation techniqueJoão Ferreira-Martins, James Howard, Becker Al-Khayatt, et al.
Journal of Clinical Lipidology|February 18, 2010
PREVENTION OF ATHEROSCLEROSIS WITH LDL-C LOWERING - LIPOPROTEIN CHANGES AND INTERACTIONS: THE SANDS STUDYWm James Howard, Marie Russell, Jerome L Fleg, et al.
American Heart Journal|October 31, 2006
Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes--the Stop Atherosclerosis in Native Diabetics Study (SANDS)Marie Russell, Jerome L Fleg, Wm James Galloway, et al.
Open Heart|June 18, 2024
Therapeutic options for neurocardiogenic syncope: a meta-analysis of randomised trials with and without blindingNandita Kaza, Michela Sorbini, Zhuang Liu, et al.
International Journal of Cancer|January 18, 2020
Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: Beyond an era of chemoradiation?Liam Masterson, James Howard, Jazmina Gonzalez-Cruz, et al.
BMJ Open|May 11, 2025
Use of 3D printed head and neck models for simulating 10 common ENT emergency procedures: a prospective validation studyUmar Rehman, Dermot Colton, Sanjeev Gupta, et al.
BMJ Open Diabetes Research & Care|March 27, 2020
Proglucagon peptide secretion profiles in type 2 diabetes before and after bariatric surgery: 1-year prospective studyKleopatra Alexiadou, Joyceline Cuenco, James Howard, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 12, 2024
A double-blind, randomised, placebo-controlled trial of the coronary sinus Reducer in refractory angina: design and rationale of the ORBITA-COSMIC trialMichael J Foley, Christopher A Rajkumar, Fiyyaz Ahmed-Jushuf, et al.
Journal of Clinical Lipidology|June 22, 2010
Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) Charlton Wilson, Chun-Chih Huang, Nawar Shara, et al.
Pageof 16

Showing results (131-140 of 153) with videos related to

Sort By:
Pageof 16
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|April 24, 2025
Free-breathing, non-contrast, three-dimensional whole-heart coronary magnetic resonance imaging for the identification of culprit and vulnerable atherosclerotic plaqueReza Hajhosseiny, Adam Hartley, Graham Cole, et al.
Journal of Cardiovascular Electrophysiology|September 20, 2018
Outcomes of paroxysmal atrial fibrillation ablation studies are affected more by study design and patient mix than ablation techniqueJoão Ferreira-Martins, James Howard, Becker Al-Khayatt, et al.
Journal of Clinical Lipidology|February 18, 2010
PREVENTION OF ATHEROSCLEROSIS WITH LDL-C LOWERING - LIPOPROTEIN CHANGES AND INTERACTIONS: THE SANDS STUDYWm James Howard, Marie Russell, Jerome L Fleg, et al.
American Heart Journal|October 31, 2006
Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes--the Stop Atherosclerosis in Native Diabetics Study (SANDS)Marie Russell, Jerome L Fleg, Wm James Galloway, et al.
Open Heart|June 18, 2024
Therapeutic options for neurocardiogenic syncope: a meta-analysis of randomised trials with and without blindingNandita Kaza, Michela Sorbini, Zhuang Liu, et al.
International Journal of Cancer|January 18, 2020
Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: Beyond an era of chemoradiation?Liam Masterson, James Howard, Jazmina Gonzalez-Cruz, et al.
BMJ Open|May 11, 2025
Use of 3D printed head and neck models for simulating 10 common ENT emergency procedures: a prospective validation studyUmar Rehman, Dermot Colton, Sanjeev Gupta, et al.
BMJ Open Diabetes Research & Care|March 27, 2020
Proglucagon peptide secretion profiles in type 2 diabetes before and after bariatric surgery: 1-year prospective studyKleopatra Alexiadou, Joyceline Cuenco, James Howard, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 12, 2024
A double-blind, randomised, placebo-controlled trial of the coronary sinus Reducer in refractory angina: design and rationale of the ORBITA-COSMIC trialMichael J Foley, Christopher A Rajkumar, Fiyyaz Ahmed-Jushuf, et al.
Journal of Clinical Lipidology|June 22, 2010
Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) Charlton Wilson, Chun-Chih Huang, Nawar Shara, et al.
Pageof 16